Jasbuzz (bictegravir,emtricitabine,tenofovir Alafenamide)

JASBUZZ Tablet is an antiretroviral drug containing the active ingredient Bictegravir, Emtricitabine, and Tenofovir Alafenamide. It is used in the treatment of HIV-1 infection. It is a Human immunodeficiency virus that mainly occurs when a person's immune system is attacked and weakened by the human immunodeficiency virus (HIV). This infection progressively weakens the immune system, making individuals more susceptible to opportunistic infections. Do not take this drug if allergic to JASBUZZ Tablet and other ingredients. During the early stages of HIV-1 treatment, some patients may experience an inflammatory response to opportunistic infections. This condition is called immune reconstitution syndrome. It can occur after starting the drug or other antiretroviral therapies. Knowing this possibility and monitoring for any signs of worsening infections or inflammatory symptoms is necessary. Report to your doctor if you have had a history of heart failure, pancreatitis, bone disease, fractures, liver or kidney problems. Patients diagnosed with pancreatitis or at risk of pancreatitis should take this combination of medicine cautiously. During the treatment, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications.